USTR SEEKS COMMENTS ON THE EXTENSION OF CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS
In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending certain expiring China 301 tariff exclusions on medical care products and designating certain additional such exclusions for the period January 1, 2021 through March 31, 2021. Such exclusions (99 in total) were extended through September 30, 2021.
n a win for GDLSK client Mirror Metals, Inc., the U.S. Court of International Trade (CIT) remanded the U.S. Department of Commerce’s earlier denial of 63 requests to exclude flat-rolled
GDLSK partner Joseph Spraragen was quoted in a Newsweek article examining how companies are handling the estimated $166 billion in tariff refunds now being returned to importers after the Supreme Court’s decision
GDLSK Partner Arthur Bodek will participate as a panelist at the International Trade Compliance Professionals Association 2026 Canada Conference being held in
Insights, News
USTR SEEKS COMMENTS ON THE EXTENSION OF CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS
In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending certain expiring China 301 tariff exclusions on medical care products and designating certain additional such exclusions for the period January 1, 2021 through March 31, 2021. Such exclusions (99 in total) were extended through September 30, 2021.
In light of various factors, including the rise in COVID-19 cases in the U.S. and the ability to obtain certain products from domestic and foreign sources, the USTR is requesting public comments on whether to extend the medical care product exclusions for up to six months. The list of the particular products in question can be found at: https://www.gdlsk.com/ustr-extends-certain-china-301-exclusions-and-designates-additional-exclusions-for-the-period-january-1-march-31-2021/?highlight=medical%20care%20products.
Comments are being accepted through September 27, 2021.
We are available to assist with the preparation of comments and to otherwise discuss China 301 mitigation strategies.
Please do not hesitate to contact Arthur Bodek or any of our attorneys for further information.
Additional News
GDLSK Secures Win at Court of International Trade for Mirror Metals in Section 232 Litigation
n a win for GDLSK client Mirror Metals, Inc., the U.S. Court of International Trade (CIT) remanded the U.S. Department of Commerce’s earlier denial of 63 requests to exclude flat-rolled
Joseph Spraragen Quoted in Newsweek on Why Some Tariff Refunds May Go Unclaimed
GDLSK partner Joseph Spraragen was quoted in a Newsweek article examining how companies are handling the estimated $166 billion in tariff refunds now being returned to importers after the Supreme Court’s decision
Additional Insights
David M. Murphy to Speak at 2026 NAFTZ Annual Conference & Exposition
Partner David M. Murphy will present at the National Association of Foreign Trade Zones Annual Conference and Exposition in San Diego, CA,
Arthur W. Bodek to Speak at the ICPA 2026 Canada Conference
GDLSK Partner Arthur Bodek will participate as a panelist at the International Trade Compliance Professionals Association 2026 Canada Conference being held in